SNN - Smith & Nephew plc

NYSE - NYSE Delayed price. Currency in USD
35.63
-0.34 (-0.95%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous close35.97
Open35.63
Bid0.00 x 0
Ask0.00 x 0
Day's range35.60 - 35.76
52-week range27.26 - 40.43
Volume261,393
Avg. volume608,029
Market cap15.27B
Beta0.48
PE ratio (TTM)18.14
EPS (TTM)1.96
Earnings dateN/A
Forward dividend & yield0.62 (1.62%)
Ex-dividend date2017-10-05
1y target est39.92
Trade prices are not sourced from all markets
  • Stocks Generating Improved Relative Strength: Smith & Nephew
    Investor's Business Daily9 days ago

    Stocks Generating Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

  • Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark
    Investor's Business Dailylast month

    Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Why MannKind, Nutanix, and Smith & Nephew Jumped Today
    Motley Foollast month

    Why MannKind, Nutanix, and Smith & Nephew Jumped Today

    On a sunny day for the market, these stocks gained ground. Find out why.

  • Reuterslast month

    Elliott Management builds stake in Smith & Nephew - Bloomberg

    It is unclear how much stake the activist investor owns or what it plans to push for at the company, according to the Bloomberg report. "We do not comment on rumour or speculation and we do not comment on the identity of our investors other than those publicly disclosed," Smith & Nephew said in an emailed statement. Elliott declined to comment.

  • Elliott's Deal Magic Is Put to the Test
    Bloomberglast month

    Elliott's Deal Magic Is Put to the Test

    The hedge fund has taken a stake in Smith & Nephew, which year after year has disappointed M&A speculators.

  • Singer's Elliott Builds a Stake in Smith & Nephew
    Bloomberglast month

    Singer's Elliott Builds a Stake in Smith & Nephew

    Billionaire Paul Singer’s hedge fund Elliott Management Corp. has built a stake in Smith & Nephew Plc, the maker of artificial hips and knees, according to people familiar with the matter.

  • Stocks Showing Improved Relative Strength: Smith & Nephew
    Investor's Business Dailylast month

    Stocks Showing Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks
    Zacks2 months ago

    Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks

    Zeroing in on dividend stocks with a solid Zacks Rank is a great way to increase the chances of beating volatile market conditions while ensuring a steady stream of cash flow. Here are three top picks in the MedTech space.

  • Reuters - UK Focus4 months ago

    Smith & Nephew buoyed by double-digit emerging markets growth

    Artificial hip and knee maker Smith & Nephew (Frankfurt: 502816 - news) reported a 3 percent rise in underlying revenue growth in the second quarter, in line with its 3-4 percent forecast for the year, helped by 13 percent growth in emerging markets. Chief Executive Olivier Bohuon said on Thursday the company was seeing good momentum, keeping it on track to deliver on full year revenue and trading margin guidance. Smith & Nephew, which competes against larger U.S. rivals in the orthopaedic replacement market, is battling to bring new technology on-stream to help it win business, with robotics a key area of innovation.

  • Reuters - UK Focus4 months ago

    Robot wars: knee surgery marks new battleground for companies

    The world's top medical technology companies are turning to robots to help with complex knee surgery, promising quicker procedures and better results in operations that often leave patients dissatisfied. Demand for artificial replacement joints is growing fast, as baby boomers' knees and hips wear out, but for the past 15 years rival firms have failed to deliver a technological advance to gain them significant market share.

  • Business Wire6 months ago

    Study results demonstrate 74% reduction in surgical site infections with use of PICO™ Single use Negative Pressure Wound Therapy system

    LONDON--(BUSINESSWIRE)-- Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, proudly supports results of an independent, randomised clinical trial 1 concluding that, in the patients ...

  • Reuters - UK Focus7 months ago

    Emerging markets growth puts Smith & Nephew on track for year

    Shares in Smith & Nephew (Frankfurt: 502816 - news) rose to a nine-month high on Friday after the artificial hip and knee maker said a strong first quarter, led by growth in emerging markets, put it on track to meet it targets for the year. The company reported underlying revenue growth of 3 percent, within the 3-4 percent range it has forecast for the year, in what analysts said was likely to be its weakest quarter. Chief Executive Olivier Bohuon said the company had made a good start to the year, highlighting emerging markets, where growth returned to double-digits, with China up by an underlying 14 percent.

  • Reuters - UK Focus7 months ago

    Smith & Nephew says M&A 'not at top of agenda' at the moment

    The chief executive of Smith & Nephew said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker. A report in the Financial Times in March said Wright Medical , a U.S. company that specialise in surgical implants for extremities like feet and ankles, could be a takeover target for the British company. S&N Chief Executive Olivier Bohuon said M&A was "always on the agenda", and he had previously pointed to extremities as one of a number of areas of interest.

  • Reuters - UK Focus7 months ago

    Smith & Nephew Q1 revenue rises 3 pct on underlying basis

    Smith & Nephew, Europe's biggest artificial hip and knee maker, reported a 3 percent rise in underlying revenue in its first quarter, helped by a return to double-digit growth in emerging markets and a ...

  • Reuters - UK Focus9 months ago

    Smith & Nephew hurt by tough markets in China and Gulf states

    Smith & Nephew (Frankfurt: 502816 - news) , Europe's biggest manufacturer of artificial hips and knees, reported a 7 percent drop in full-year trading profit, missing analysts' forecasts, as tough conditions in China and Saudi Arabia kept growth in check. Smith & Nephew reported trading profit of $1.02 billion on revenue up 2 percent on an underlying basis at $4.67 billion.

  • Reuters - UK Focus9 months ago

    Falls in Smith & Nephew, miners weigh on Britain's FTSE

    Britain's top share index steadied on Thursday as falls among mining stocks weighed, while Smith & Nephew dropped after posting disappointing results. The blue chip FTSE 100 index was up 0.1 percent at 7,192.70 points by 1028 GMT, underperforming the broader European market. Artificial hip and knee maker Smith & Nephew booked a 7 percent drop in full-year trading profit, missing analysts' forecasts, hit by difficult market conditions in China and Saudi Arabia.

  • Reuters - UK Focus9 months ago

    BUZZ-Smith & Nephew: bottom of the FTSE as China weakness hits results

    ** Artificial joint maker Smith & Nephew falls 4.3 pct, bottom of the FTSE 100, after FY profits fell 7 pct ** Co cites weakness in China for fall ** Revenues miss analyst estimates , profit also lower ...

  • Elliott Said to Build Stake in Smith & Nephew
    Bloomberg Videolast month

    Elliott Said to Build Stake in Smith & Nephew

    Oct.11 -- Activist investor Paul Singer is honing in on Europe, building stakes in an engineering and healthcare company. An after hour statement revealed Singer's hedge fund Elliott Management added German engineering firm GEA to its portfolio and according to people familiar with the matter, it also took a stake in the British company Smith & Nephew. Bloomberg's Ruth David reports on "Bloomberg Markets: European Open."

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes